SE0200205D0 - Method - Google Patents
MethodInfo
- Publication number
- SE0200205D0 SE0200205D0 SE0200205A SE0200205A SE0200205D0 SE 0200205 D0 SE0200205 D0 SE 0200205D0 SE 0200205 A SE0200205 A SE 0200205A SE 0200205 A SE0200205 A SE 0200205A SE 0200205 D0 SE0200205 D0 SE 0200205D0
- Authority
- SE
- Sweden
- Prior art keywords
- hexahydroquinolin
- benzonitrile
- oxo
- trifluoromethyl
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0200205A SE0200205D0 (sv) | 2002-01-24 | 2002-01-24 | Method |
EP03731874A EP1478627A1 (en) | 2002-01-24 | 2003-01-23 | Method |
PCT/SE2003/000114 WO2003062203A1 (en) | 2002-01-24 | 2003-01-23 | Method |
JP2003562085A JP2005520813A (ja) | 2002-01-24 | 2003-01-23 | 方法 |
CNA03802764XA CN1622938A (zh) | 2002-01-24 | 2003-01-23 | 方法 |
CA002473386A CA2473386A1 (en) | 2002-01-24 | 2003-01-23 | Method |
US10/502,191 US7012145B2 (en) | 2002-01-24 | 2003-01-23 | Method |
BR0307091-3A BR0307091A (pt) | 2002-01-24 | 2003-01-23 | Método para produzir um composto, composto, uso do mesmo, composição farmacêutica, e, método para tratar uma doença ou condição que resulte de ativação inapropriada do músculo liso |
MXPA04007055A MXPA04007055A (es) | 2002-01-24 | 2003-01-23 | Metodo. |
KR10-2004-7011406A KR20040077782A (ko) | 2002-01-24 | 2003-01-23 | 방법 |
ZA200405860A ZA200405860B (en) | 2002-01-24 | 2004-07-22 | Method. |
NO20043433A NO20043433L (no) | 2002-01-24 | 2004-08-17 | Fremgangsmate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0200205A SE0200205D0 (sv) | 2002-01-24 | 2002-01-24 | Method |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0200205D0 true SE0200205D0 (sv) | 2002-01-24 |
Family
ID=20286758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0200205A SE0200205D0 (sv) | 2002-01-24 | 2002-01-24 | Method |
Country Status (12)
Country | Link |
---|---|
US (1) | US7012145B2 (sv) |
EP (1) | EP1478627A1 (sv) |
JP (1) | JP2005520813A (sv) |
KR (1) | KR20040077782A (sv) |
CN (1) | CN1622938A (sv) |
BR (1) | BR0307091A (sv) |
CA (1) | CA2473386A1 (sv) |
MX (1) | MXPA04007055A (sv) |
NO (1) | NO20043433L (sv) |
SE (1) | SE0200205D0 (sv) |
WO (1) | WO2003062203A1 (sv) |
ZA (1) | ZA200405860B (sv) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006065842A2 (en) * | 2004-12-13 | 2006-06-22 | Synta Pharmaceuticals Corp. | 5,6,7,8-tetrahydroquinolines and related compounds and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455253A (en) * | 1992-10-20 | 1995-10-03 | Zeneca Limited | Heterocyclic derivatives |
GB9407432D0 (en) | 1994-04-14 | 1994-06-08 | Zeneca Ltd | Heterocyclic derivative |
DE60131660D1 (de) * | 2000-08-02 | 2008-01-10 | Astrazeneca Ab | Verfahren zur asymetrischen synthese von substituierten 1,4-dihydropyridin-derivaten |
-
2002
- 2002-01-24 SE SE0200205A patent/SE0200205D0/sv unknown
-
2003
- 2003-01-23 CA CA002473386A patent/CA2473386A1/en not_active Abandoned
- 2003-01-23 KR KR10-2004-7011406A patent/KR20040077782A/ko not_active Application Discontinuation
- 2003-01-23 WO PCT/SE2003/000114 patent/WO2003062203A1/en active Application Filing
- 2003-01-23 US US10/502,191 patent/US7012145B2/en not_active Expired - Fee Related
- 2003-01-23 JP JP2003562085A patent/JP2005520813A/ja not_active Abandoned
- 2003-01-23 CN CNA03802764XA patent/CN1622938A/zh active Pending
- 2003-01-23 EP EP03731874A patent/EP1478627A1/en not_active Withdrawn
- 2003-01-23 MX MXPA04007055A patent/MXPA04007055A/es unknown
- 2003-01-23 BR BR0307091-3A patent/BR0307091A/pt not_active Application Discontinuation
-
2004
- 2004-07-22 ZA ZA200405860A patent/ZA200405860B/en unknown
- 2004-08-17 NO NO20043433A patent/NO20043433L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US7012145B2 (en) | 2006-03-14 |
MXPA04007055A (es) | 2004-10-11 |
CN1622938A (zh) | 2005-06-01 |
CA2473386A1 (en) | 2003-07-31 |
EP1478627A1 (en) | 2004-11-24 |
KR20040077782A (ko) | 2004-09-06 |
US20050080104A1 (en) | 2005-04-14 |
NO20043433L (no) | 2004-08-17 |
BR0307091A (pt) | 2004-12-28 |
JP2005520813A (ja) | 2005-07-14 |
WO2003062203A1 (en) | 2003-07-31 |
ZA200405860B (en) | 2005-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE304358T1 (de) | (s,s)-reboxetin zur behandlung von migränekopfschmerzen | |
BG108225A (en) | Thiohydantoins and use thereof for treating diabetes | |
EG24978A (en) | Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment. | |
DE602004017037D1 (de) | 2,3-dihydro-6-nitroimidazoä2,1-büoxazolverbindungen zur behandlung von tuberkulose | |
MY136520A (en) | Novel compounds | |
MXPA03007140A (es) | Derivados de carbolina. | |
BRPI0307351B8 (pt) | composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto | |
DE60214703D1 (de) | Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen | |
UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
ATE494884T1 (de) | Oxidative zusammensetzung zur behandlung von keratinfasern, die spezielle aminosilikone enthält | |
PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
ATE388135T1 (de) | Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
WO2005016883A3 (en) | Acrylamide derivatives as vla-1 integrin antagonists and uses thereof | |
ATE348812T1 (de) | Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf) | |
TW200502234A (en) | Pyridyloxymethyl and benzisoxazole azabicyclic derivatives | |
AU2001290480A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
DE10190485T1 (de) | Verfahren zur Herstellung von 5-Cyano-1-(4-fluorphenyl)-1,3-dihydroisobenzofuranen | |
EP1551388A4 (en) | COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME | |
SE0200843D0 (sv) | Chemical compounds | |
IL145645A0 (en) | N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists | |
EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
DE50205466D1 (de) | Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen | |
WO2002076396A3 (en) | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases | |
PL373192A1 (en) | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |